ABO2203
/ Suzhou Abogen Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 16, 2025
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
(clinicaltrials.gov)
- P1 | N=26 | Recruiting | Sponsor: Ruijin Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology
1 to 1
Of
1
Go to page
1